NCT05140356

Brief Summary

Autism spectrum disorder (ASD) is a common and complex neurodevelopmental disorder, which is characterized by impairments of social communication, social reciprocity, as well as restricted and repetitive behaviors (RRB). The unclear pathogenesis of ASD, its increasing prevalence, and its poor clinical diagnosis and treatment effect have caused a serious economic and mental burden on patients and their families. As a new non-invasive neuroelectrophysiological technique, transcranial magnetic stimulation (TMS) has been used more and more in the interventional treatment of autism. The current project aims to explore the influence of TMS on brain plasticity in autism by using TMS for interventional treatment of autism and provide guidelines for the intervention and treatment of autism by evaluating the efficiency of these methods.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2019

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

November 3, 2021

Completed
28 days until next milestone

First Posted

Study publicly available on registry

December 1, 2021

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

December 1, 2021

Status Verified

November 1, 2021

Enrollment Period

5.6 years

First QC Date

November 3, 2021

Last Update Submit

November 21, 2021

Conditions

Keywords

autismBrain Plasticitytranscranial magnetic stimulationMagnetic Resonance Imagingeye movementgut microbiome

Outcome Measures

Primary Outcomes (1)

  • The gray matter volume of children with autism at baseline and after repeated transcranial magnetic stimulation intervention as assessed by magnetic resonance imaging.

    Longitudinal study of the gray matter volume will be conducted in children with autism at baseline and after repeated transcranial magnetic stimulation intervention based on structural magnetic resonance image. Longitudinal effect of repeated transcranial magnetic stimulation intervention on brain structure in children with autism will be assessed by Voxel-based morphometry analysis for gray matter volume changes.

    through study completion, an average of 1 year

Secondary Outcomes (1)

  • The functional connectivity of whole brain of whole brain in children with autism with repeated transcranial magnetic stimulation intervention as assessed by functional magnetic resonance imaging.

    through study completion, an average of 1 year

Study Arms (3)

High amplitude repeated transcranial magnetic stimulation

EXPERIMENTAL

Applied high amplitude repeated transcranial magnetic stimulation

Device: Applied high amplitude repeated transcranial magnetic stimulation

Low amplitude repeated transcranial magnetic stimulation

EXPERIMENTAL

Applied low amplitude repeated transcranial magnetic stimulation

Device: Applied low amplitude repeated transcranial magnetic stimulation

healthy control group

NO INTERVENTION

No intervention

Interventions

Each mode required 20 stimuli(100%RMT) for 20 minutes each time, 5 times a week

High amplitude repeated transcranial magnetic stimulation

Each mode required 20 stimuli(15%RMT) for 20 minutes each time, 5 times a week

Low amplitude repeated transcranial magnetic stimulation

Eligibility Criteria

Age2 Years - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age range from 2 to 8 years old. Clinical DSM-IV diagnosis of autism.

You may not qualify if:

  • Subjects with other neurodevelopmental diseases Subjects with contraindications to MRI.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Life Science and Technology, University of Electronic Science and Technology

Chengdu, Sichuan, 610054, China

RECRUITING

MeSH Terms

Conditions

Autistic Disorder

Condition Hierarchy (Ancestors)

Autism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Central Study Contacts

Huafu Chen

CONTACT

Huafu Chen, Study Principal Investigator

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

November 3, 2021

First Posted

December 1, 2021

Study Start

May 1, 2019

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

December 1, 2021

Record last verified: 2021-11

Locations